Generation of human high-affinity antibodies specific for the fibroblast activation protein by guided selection

被引:25
作者
Schmidt, A
Müller, D
Mersmann, M
Wüest, T
Gerlach, E
Garin-Chesa, P
Rettig, WJ
Pfizenmaier, K
Moosmayer, D
机构
[1] Univ Stuttgart, Inst Zellbiol & Immunol, D-70569 Stuttgart, Germany
[2] Boehringer Ingelheim Pharma KG, Biberach, Germany
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2001年 / 268卷 / 06期
关键词
fibroblast activation protein; guided selection; human antibody; minibody; tumor therapy;
D O I
10.1046/j.1432-1033.2001.02046.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four completely human antibody derivatives [single-chain-antibody fragments (scFvs)] with specificity for the general tumor stroma marker fibroblast activation protein (FAP) were isolated by guided selection. Highly diverse IgG, IgM and IgD isotypes comprising heavy-chain variable domain libraries were generated using cDNAs derived from diverse lymphoid organs of a multitude of donors. Three of the human scFvs were converted into bivalent minibodies and expressed in eukaryotic cells for further functional characterization. Binding-competition studies and analysis by fluorescence-activated cell sorting showed high-affinity binding (10-20 nm) for two clones and recognition of the same epitope as the murine guiding antibody. The minibodies were successfully used for immunohistology of a variety of human carcinoma biopsies, revealing specific staining of stromal fibroblasts. Therefore, they should be suitable for in vivo diagnostic and tumor-targeting studies and, because of their completely human origin, be superior to murine or humanized antibody derivatives.
引用
收藏
页码:1730 / 1738
页数:9
相关论文
共 41 条
[1]  
Baca M, 1997, J BIOL CHEM, V272, P10678
[2]   Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent [J].
Beiboer, SHW ;
Reurs, A ;
Roovers, RC ;
Arends, JW ;
Whitelegg, NR ;
Rees, AR ;
Hoogenboom, HR .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 296 (03) :833-849
[3]   A SURFACE EXPRESSION VECTOR FOR ANTIBODY SCREENING [J].
BREITLING, F ;
DUBEL, S ;
SEEHAUS, T ;
KLEWINGHAUS, I ;
LITTLE, M .
GENE, 1991, 104 (02) :147-153
[4]   HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY [J].
CARTER, P ;
PRESTA, L ;
GORMAN, CM ;
RIDGWAY, JBB ;
HENNER, D ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, C ;
CARVER, ME ;
SHEPARD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4285-4289
[5]   X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY - STRUCTURAL INDICATIONS OF THE KEY ROLE OF V(H) RESIDUES 59 TO 65 [J].
EIGENBROT, C ;
GONZALEZ, T ;
MAYEDA, J ;
CARTER, P ;
WERTHER, W ;
HOTALING, T ;
FOX, J ;
KESSLER, J .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1994, 18 (01) :49-62
[6]   IN-VITRO ASSEMBLY OF REPERTOIRES OF ANTIBODY CHAINS ON THE SURFACE OF PHAGE BY RENATURATION [J].
FIGINI, M ;
MARKS, JD ;
WINTER, G ;
GRIFFITHS, AD .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 239 (01) :68-78
[7]  
Figini M, 1998, CANCER RES, V58, P991
[8]   New perspectives in clinical oncology from angiogenesis research [J].
Folkman, J .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2534-2539
[9]   CELL-SURFACE GLYCOPROTEIN OF REACTIVE STROMAL FIBROBLASTS AS A POTENTIAL ANTIBODY TARGET IN HUMAN EPITHELIAL CANCERS [J].
GARINCHESA, P ;
OLD, LJ ;
RETTIG, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7235-7239
[10]   MOLECULAR-CLONING AND EXPRESSION OF HUMAN AND RAT-TUMOR NECROSIS FACTOR RECEPTOR CHAIN (P60) AND ITS SOLUBLE DERIVATIVE, TUMOR NECROSIS FACTOR-BINDING PROTEIN [J].
HIMMLER, A ;
MAURERFOGY, I ;
KRONKE, M ;
SCHEURICH, P ;
PFIZENMAIER, K ;
LANTZ, M ;
OLSSON, I ;
HAUPTMANN, R ;
STRATOWA, C ;
ADOLF, GR .
DNA AND CELL BIOLOGY, 1990, 9 (10) :705-715